(Total Views: 329)
Posted On: 06/27/2019 11:40:45 AM
Post# of 39

$ASMB News Article - Assembly Biosciences Announces First Patient Dosed with ABI-M201 in Phase 1b Clinical Trial for Mildly to Moderately Active Ulcerative Colitis https://marketwirenews.com/news-releases/asse...23428.html


My Twitter: WhyteStocks